NOVO NORDISK will reduce the price of blockbuster weight loss drugs to $ 499 for certain patients who pay using their own money without insurance. I said on Wednesday.
Due to the movement, more patients can start taking drugs. However, the decision is limited because it does not lower the price of patients who have revolutionized obesity treatment to patients who are having health insurance or employers who are struggling with huge pharmaceutical costs such as Wegovy.
In order to qualify for a price cut, the patient must not be insured or commercially guaranteed for plans that do not cover the drug. Previously, there was a drug manufacturer. I suggested a coupon It allows those patients to supply drugs for $ 650 a month. Wednesday movements lead to $ 150 a month for such patients.
This new product is not available to tens of millions of Americans under insurance through government programs such as Medicare and Medicaid. To get drugs in Novo Nordisk, these patients usually require more than $ 1,300 a month in a pharmacy.
NOVO NORDISK will provide discounted products through an online pharmacy and send a prescription to the patient through mail. This is a strategy that drug manufacturers use more and more to control the distribution of product distribution. Rival of Novo Nordis, Eli Lily, There is a similar proposal In the case of vials of weight loss drugs, zepbound of less than $ 499 a month.
The price cut of Novo Nordisk is expected to actually sign a few weeks before dividing WEGOVY’s inexpensive copycat version into the market.
Over the past few years, patients who lower prices have been converted into a version created through a drug-intervention mixing process known as compounding, which is allowed by the regulatory agency when the patented product is insufficient.
The patient often pays about $ 150 a month in a pocket for the complex version of Wegovy. calculation 2 million patients In the last year, we have gained drugs in this way.
But last month, the Food and Drug Administration proclaimed the WEGOVY tribe and ordered complex to stop surgery until April or May. NOVO NORDISK now has the opportunity to remind people of displaced people who rely on welfare and increase the sales of the official version of the drug.
